Living with Ankylosing Spondylitis: The Blog

A blog for and by people living with AS

Efficacy in current practice of switching between anti-tumour necrosis factor-a agents in spondyloarthropathies

The Tumor-Necrosis-Factor alpha (TNF-a) blockers are biologic medications that have shown great promise in treating ankylosing spondylitis. They have been shown to be highly effective in treating not only the arthritis of the joints but the spinal arthritis associated with ankylosing spondylitis and related diseases.

This study looked at the effectiveness of switching between TNF-a medications to see if one would work when another had not.

The authors conclude that, “In the event of failure or intolerance to anti-TNF-a in the treatment of [spondyloarthropathies], performing a first or second switch produces a satisfactory therapeutic response.

via Press – News – 462 – Efficacy in current practice of switching between anti-tumour necrosis factor-a agents in spondyloarthropathies.

Advertisements

No comments yet»

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: